Invention Grant
US08663147B2 Treatment of thromboangiitis obliterans by removal of autoantibodies
有权
通过去除自身抗体来治疗闭塞性血栓闭塞症
- Patent Title: Treatment of thromboangiitis obliterans by removal of autoantibodies
- Patent Title (中): 通过去除自身抗体来治疗闭塞性血栓闭塞症
-
Application No.: US12988267Application Date: 2009-04-20
-
Publication No.: US08663147B2Publication Date: 2014-03-04
- Inventor: Gert Baumann
- Applicant: Gert Baumann
- Agency: Agris & von Natzmer LLP
- Agent Joyce von Natzmer
- Priority: EP08075309 20080418
- International Application: PCT/EP2009/002993 WO 20090420
- International Announcement: WO2009/143944 WO 20091203
- Main IPC: A61M37/00
- IPC: A61M37/00
Abstract:
The invention relates to the use of a specific ligand for antibodies, preferably autoantibodies in the manufacture of a column for the treatment of thromboangiitis obliterans. The invention pertains furthermore to the apharesis column with at least one anti-IgG antibody for the treatment of thromboangiitis obliterans.
Public/Granted literature
- US20110105980A1 TREATMENT OF THROMBOANGIITIS OBLITERANS BY REMOVAL OF AUTOANTIBODIES Public/Granted day:2011-05-05
Information query
IPC分类:
